Trials / Completed
CompletedNCT04798664
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,228 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.
Detailed description
We will conduct a 4-arm randomized trial comparing 4 interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among smokers in underserved demographic groups. The 3,200 participants to be enrolled will be current smokers who are Black, Hispanic, and/or have low socioeconomic status (defined as household income \<200% of the federal poverty line or a high school education or less) or rural residence who are referred for low-dose computed tomography (LDCT) screening at 4 large health systems. All adult patients with LDCT orders will be further screened for eligibility. Eligible patients will enroll with opt-out consent and complete the study using the NIH-funded Way to Health online research portal. The primary outcome will be biochemically confirmed, sustained abstinence from smoking tobacco for 6 months following participants' selected quit dates. Relapse rates will be tracked at 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Removal of Financial Barriers | Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications |
| BEHAVIORAL | Financial Incentives | Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
| BEHAVIORAL | Mobile Health Application | Episodic future thinking tool to overcome temporal discounting of future |
Timeline
- Start date
- 2021-05-17
- Primary completion
- 2024-11-04
- Completion
- 2025-04-29
- First posted
- 2021-03-15
- Last updated
- 2026-02-25
- Results posted
- 2026-02-25
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04798664. Inclusion in this directory is not an endorsement.